Cardioline Acquires Cardios

Cardioline, a leader in cardiac diagnostics and telecardiology, has acquired Cardios, an innovator in Holter monitoring and ambulatory blood pressure monitoring (ABPM) based in Brazil, from Halma.

The transaction, supported by ARCHIMED, accelerates Cardioline’s telecardiology strategy and signals a new chapter in the advancement of comprehensive, connected, and patient-centered cardiac diagnostics worldwide.

The companies’ complementary strengths span the full cardiac diagnostic journey. Cardioline’s full portfolio will be further complemented with Cardios’s specialized regional expertise in Holter and ABPM technologies. Together, the combined entity is positioned to deliver a broader, more integrated suite of cardiac diagnostic solutions to physicians, healthcare institutions, and patients across global markets.

“This acquisition is an exciting moment for Cardioline and a clear expression of our vision: to power a better cardiac care globally. Cardios has earned an exceptional reputation for precision and reliability over decades, and their deep expertise in Holter and ABPM is the perfect complement to our global portfolio. Together, we are creating a truly end-to-end solution that supports every step of the cardiac care pathway,” said Luis Meireles, CEO, Cardioline.

“By combining Cardioline’s global reach with the clinical expertise, market proximity, and the reliability built by Cardios in Holter and ABPM over decades, we strengthen our shared goal of redefining standards in cardiac diagnostics and generating a positive, lasting impact for physicians, healthcare institutions, and patients,” added Erica Chriguer, Cardios.

Other Pharma Industry Acquisitions

Check out Contract Pharma’s Pharmaceutical Industry Mergers & Acquisitions Roundup.